Mallinckrodt Plc (MNKKQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MNKKQ | SLGL | MGX | ||
| Company | Mallinckrodt Plc | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.0181 | 79.89 | 1.3600 | ||
| High | 0.0248 | 85.32 | 1.4100 | ||
| Low | 0.0173 | 79.89 | 1.3200 | ||
| Latest | 0.0200 | 83.50 | 1.3400 | ||
| Change | +0.0019 | +4.28 | unch | ||
| % Change | +10.50% | +5.40% | unch | ||
| Volume | 290,500 | 56,900 | 487,900 | ||
| 20-Day Average Volume | 688,165 | 41,185 | 287,545 | ||
| Previous Close | 0.0181 | 79.22 | 1.3400 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.0650 | 79.86 | 1.4618 | ||
| 20-Day Raw Stochastic | 19.21% | 63.32% | 15.65% | ||
| 20-Day Relative Strength | 28.25 | 53.70 | 42.33 | ||
| Weighted Alpha | -92.58 | +644.07 | -26.36 | ||
| Today's Opinion | 100% Sell | 88% Buy | 100% Sell | ||
| Previous Opinion | 100% Sell | 72% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -68.25% since 06/09/22 | +5.60% since 03/25/26 | -3.60% since 03/25/26 | ||
| Low | 0.0010 on 06/13/22 | 65.07 on 03/30/26 | 1.2500 on 03/30/26 | ||
| High | 0.0680 on 06/10/22 | 85.32 on 04/01/26 | 1.4300 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -74.52% since 05/16/22 | -8.92% since 02/27/26 | -11.84% since 02/27/26 | ||
| Low | 0.0010 on 06/13/22 | 61.92 on 03/23/26 | 1.2500 on 03/30/26 | ||
| High | 0.0999 on 05/19/22 | 97.97 on 03/03/26 | 1.8250 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | -83.05% since 03/16/22 | +98.15% since 12/31/25 | -17.28% since 12/31/25 | ||
| Low | 0.0010 on 06/13/22 | 41.68 on 01/02/26 | 1.2500 on 03/30/26 | ||
| High | 0.1300 on 04/18/22 | 97.97 on 03/03/26 | 1.8600 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | -88.21% since 12/16/21 | +183.05% since 10/01/25 | -43.93% since 10/01/25 | ||
| Low | 0.0010 on 06/13/22 | 27.00 on 10/02/25 | 1.2500 on 03/30/26 | ||
| High | 0.2439 on 02/15/22 | 97.97 on 03/03/26 | 3.9500 on 10/16/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,696 | 222,600 | 50,412 | ||
| Shares Outstanding, K | 84,783 | 2,810 | 37,621 | ||
| Annual Sales | 1,914,300,000 | 19,390,000 | 25,210,000 | ||
| Annual Net Income | -911,200,000 | -6,130,000 | -87,870,000 | ||
| Last Quarter Sales | 490,900,000 | 700,000 | 3,910,000 | ||
| Last Quarter Net Income | -119,600,000 | -2,990,000 | -22,530,000 | ||
| 60-Month Beta | 2.72 | 1.30 | 0.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.95 on 05/03/22 | -1.07 on 03/19/26 | -0.60 on 03/05/26 | ||
| Latest Earnings Date | 06/27/23 | 05/22/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||